Coronary angioplasty is the most frequent method used for coronary revascularisation. Recommendations about its application are well-established. The elderly are a growing population with a high prevalence of ischaemic heart disease, especially with unstable presentation. Despite the worse prognostic reliable to these patients, aggressive treatments are often lacking, particularly the achievement of percutaneous coronary interventions. Most of the time excluded from the largest clinical trials, subject to more complications, bleeding and renal failure for example, the recommendations seem more difficult to implement. The authors propose an update about angioplasty over 80 years. The results of many important registries suggest that octogenarians are potential good candidates for angioplasty, without underestimating the complications inherent with the procedure. However, the selection of patients, improved materials, the choice of the route approach and the development of new molecules can significantly reduce this morbidity. In addition, largest inclusion of elderly in clinical trials and specific studies should allow for more focused recommendations.